Tessella. Complex problems. Solved.

Posts Tagged ‘clinical-technolgies’

2010 Accelrys European User Group Meeting; October 26-28th, Barcelona, Spain

Tuesday, September 14th, 2010

Tessella are sponsoring this year’s 2010 Accelrys European User Group Meeting, taking place at the Dolce Sitges Hotel in Barcelona, Spain on October 26-28th 2010. Mark Roberts from Tessella and Ed Ainscow from AstraZeneca will be speaking at the event.  The title of their abstract is ‘A Flexible Platform for Processing High-Content Screening Data’ which [...]

Drug Discovery World: ‘Scientists Instincts Often Impaired’

Optibrium, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions…read more

LabBulletin: New paper from Optibrium and Tessella illustrates scientists’ instincts are often impaired by human cognitive biases when making drug discovery decisions

Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions…read more

On Demand Webinar: FDA guidance on adaptive design – what does it means for you?

Tuesday, June 22nd, 2010

In Feb 2010 the FDA issued a draft guidance for industry on “Adaptive Design Clinical Trials for Drugs and Biologics” (pdf). Join Tom Parke in this on-demand webinar as he quizzes adaptive trial gurus Prof Don Berry and Dr Scott Berry on the implications of the FDA Guidance. Tom will be getting answers to the key [...]

Webinar 8th June: FDA guidance on adaptive design – what does it mean for you?

Wednesday, May 12th, 2010

Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST)  17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]

11th Annual Drug Discovery Leaders Summit, June 9-10th, 2010, Montreux, Switzerland

Wednesday, May 12th, 2010

Tessella are proudly sponsoring the 11th Annual Drug Discovery Leaders Summit taking place on June 9-10th, 2010 in Montreux, Switzerland. Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 45 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well [...]

FACTS User Group Meeting 2010 – July 20th – 21st, Cambridge, Massachusetts, USA

Wednesday, May 12th, 2010

The FACTS User Group Meeting will be taking place on July 20th and 21st 2010 at Le Meridien, Cambridge, Massachusetts, USA. For further information about this event, please email info@tessella.com. For information about FACTS and clinical trial solutions, visit www.smarterclinicaltrials.com

PRESS RELEASE: European preview for Tessella’s combination therapies trial design software

Tom Parke unveils prototype version of combination finder trial design software at IQPC’s Optimising Clinical Development in Oncology conference. Oxford, UK | 27 April 2010. Today, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments previewed clinical trial design software that addresses the challenge of designing [...]

Bio Research Online: Tom Parke Unveils Prototype Version Of Combination Finder Trial Design Software At CHI’s Combination Therapies Conference

Recently, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments previewed clinical trial design software that addresses the challenge of designing Phase 1 trials for combination therapies…read more

EPC: Smart Designs

Tom Parke at Tessella plc highlights the advantage of designing trials that use techniques such as modelling and adaptation…read more